• General education to advance policies that support innovation in the medical device industry. Issues related to coverage and reimbursement of diagnostic tests, including H.R.2369 the VALID Act of 2023. Issues related to FDA regulation of medical devices. Issues related to medical device sterilization and the use of ethylene oxide to sterilize medical devices. Issues related to PFAS Chemical regulation.
• General education to advance policies that support innovation in the medical device industry. Implementation of the Transitional Coverage for Emerging Technologies policies. H.R.1691, Ensuring Patient Access to Critical Breakthrough Products Act.
• Issues related to R&D tax credit; H.R.7024, Tax Relief for American Families and Workers Act of 2024.

Duration: September 1, 2014 to January 1, 2015

General Issues: Health Issues, Medicare/Medicaid, Taxation/Internal Revenue Code, Medical/Disease Research/Clinical Labs, Budget/Appropriations

Spending: about $190,000 (But it's complicated. Here's why.)

It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.

Agencies lobbied since 2014: U.S. Senate, House of Representatives